Aperio Group, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 179 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$3,575,000
+78.7%
83,719
+10.0%
0.01%
+57.1%
Q3 2020$2,001,000
+15.3%
76,121
+17.6%
0.01%
+16.7%
Q2 2020$1,735,000
+80.4%
64,709
+21.0%
0.01%
+50.0%
Q1 2020$962,000
+18.5%
53,464
+16.8%
0.00%
+33.3%
Q4 2019$812,000
+40.2%
45,779
+22.6%
0.00%
+50.0%
Q3 2019$579,000
+25.9%
37,333
+39.5%
0.00%0.0%
Q2 2019$460,000
+11.4%
26,756
+4.4%
0.00%0.0%
Q1 2019$413,000
+20.4%
25,636
+9.2%
0.00%0.0%
Q4 2018$343,000
+12.5%
23,467
+39.9%
0.00%
+100.0%
Q3 2018$305,000
+15.5%
16,777
+7.2%
0.00%0.0%
Q2 2018$264,000
-24.1%
15,643
-12.0%
0.00%
-50.0%
Q1 2018$348,000
-0.9%
17,769
+2.4%
0.00%0.0%
Q4 2017$351,000
+29.5%
17,347
+11.1%
0.00%0.0%
Q3 2017$271,000
-26.8%
15,618
-45.8%
0.00%0.0%
Q2 2017$370,000
+96.8%
28,823
+99.2%
0.00%
+100.0%
Q1 2017$188,000
+34.3%
14,470
+2.5%
0.00%0.0%
Q4 2016$140,000
-36.4%
14,120
-22.3%
0.00%
-50.0%
Q3 2016$220,000
+107.5%
18,178
+48.4%
0.00%
+100.0%
Q2 2016$106,000
-25.4%
12,252
+16.0%
0.00%0.0%
Q3 2015$142,000
-33.6%
10,566
+11.7%
0.00%
-50.0%
Q2 2015$214,0009,4590.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders